Related Experiment Video
Updated: Jan 25, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Melanoma proteomics suggests functional differences related to mutational status
Lucía Trilla-Fuertes1, Angelo Gámez-Pozo1,2, Guillermo Prado-Vázquez1,2
1Biomedica Molecular Medicine SL, Madrid, Spain.
Abstract:
Melanoma is the most lethal cutaneous cancer. New drugs have recently appeared; however, not all patients obtain a benefit of these new drugs. For this reason, it is still necessary to characterize melanoma at molecular level. The aim of this study was to explore the molecular differences between melanoma tumor subtypes, based on BRAF and NRAS mutational status. Fourteen formalin-fixed, paraffin-embedded melanoma samples were analyzed using a high-throughput proteomics approach, combined with probabilistic graphical models and Flux Balance Analysis, to characterize these differences. Proteomics analyses showed differences in expression of proteins related with fatty acid metabolism, melanogenesis and extracellular space between BRAF mutated and BRAF non-mutated melanoma tumors. Additionally, probabilistic graphical models showed differences between melanoma subgroups at biological processes such as melanogenesis or metabolism. On the other hand, Flux Balance Analysis predicts a higher tumor growth rate in BRAF mutated melanoma samples. In conclusion, differential biological processes between melanomas showing a specific mutational status can be detected using combined proteomics and computational approaches.
Insights
Understanding melanoma molecular differences is key, as new drugs benefit only some patients. This study used proteomics and computational methods to find distinct molecular features in BRAF mutated versus non-mutated melanoma.
Area of Science:
- Oncology
- Proteomics
- Bioinformatics
Background:
- Melanoma is the deadliest skin cancer, with new therapies showing variable patient response.
- Personalized treatment requires deeper molecular characterization of melanoma subtypes.
- Identifying molecular distinctions based on BRAF and NRAS mutational status is crucial.
Purpose of the Study:
- To investigate molecular differences between melanoma subtypes defined by BRAF and NRAS mutational status.
- To apply high-throughput proteomics and computational modeling for melanoma subtyping.
- To correlate molecular profiles with tumor growth characteristics.
Main Methods:
- Analysis of 14 formalin-fixed, paraffin-embedded melanoma samples.
- High-throughput proteomics to identify protein expression differences.
- Probabilistic graphical models and Flux Balance Analysis for computational characterization.
Main Results:
- Proteomics revealed differential protein expression in fatty acid metabolism, melanogenesis, and extracellular space between BRAF mutated and non-mutated tumors.
- Computational models identified distinct biological processes, including melanogenesis and metabolism, across melanoma subgroups.
- Flux Balance Analysis predicted a higher tumor growth rate in BRAF mutated melanoma samples.
Conclusions:
- Combined proteomics and computational approaches can detect differential biological processes in melanoma based on mutational status.
- Molecular subtyping of melanoma holds promise for targeted therapeutic strategies.
- Understanding BRAF mutational impact on melanoma biology is essential for treatment optimization.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Mutation, Gene Flow, and Genetic Drift
Difference from Background: Limit of Detection
The LOD indicates the presence or absence...
Electric Potential and Potential Difference
When a test charge moves from the initial to the final position, the electric potential difference between those positions is defined as the ratio of the change in the potential energy to the charge on the...

